Income Statement
BIODESIX INC
BDSX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
88.50 | 71.32 | 49.09 | 38.21 | 54.51 | 45.56 |
|
Cost of Revenue
|
7.90 | 9.15 | - | - | - | - |
|
Gross Profit
|
80.60 | 62.18 | 49.09 | 38.21 | 54.51 | 45.56 |
|
Operating Expenses
|
116.37 | 105.82 | 90.43 | 88.80 | 95.45 | 68.49 |
|
Research & Development
|
12.00 | 9.56 | 9.99 | 13.10 | 12.79 | 10.82 |
|
Selling, General & Administrative
|
87.55 | 80.45 | 67.39 | 61.46 | 50.52 | 34.86 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-35.77 | -43.64 | -41.34 | -50.59 | -40.94 | -22.93 |
|
Non-Operating Income
|
-7.39 | -8.43 | - | - | - | - |
|
Interest Income
|
- | - | - | - | - | 0.02 |
|
Interest Expense
|
7.72 | 8.26 | 9.54 | 8.07 | 4.51 | 7.60 |
|
Other Non-Op Income / Expense
|
- | - | -10.80 | -14.86 | -2.22 | -8.42 |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-35.27 | -42.93 | -52.15 | -65.45 | -43.16 | -31.35 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-30.10 | -37.87 | -38.01 | -46.99 | -37.76 | -20.03 |
|
Earnings Per Share (Basic)
|
-4.67 | -0.33 | -0.64 | -1.55 | - | - |
|
Diluted EPS
|
-4.67 | -0.33 | -0.64 | -1.55 | - | - |
|
Weighted Average Shares
|
7.55 | 129.67 | 82.11 | 42.10 | - | - |
|
Diluted Weighted Avg Shares
|
7.55 | 129.67 | 82.11 | 42.10 | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - |